We are live on
!
Find out more
B
Brightworth Portfolio holdings
AUM
$933M
1-Year Est. Return
15.08%
This Fund
S&P 500
This Quarter
Est. Return
-4.04%
1 Year Est. Return
-15.08%
3 Year Est. Return
+21.7%
5 Year Est. Return
+55.97%
10 Year Est. Return
–
AUM
$987M
AUM Growth
-$106M
(-9.7%)
Cap. Flow
-$51.5M
Cap. Flow
% of AUM
-5.22%
Top 10 Holdings %
Top 10 Hldgs %
59.26%
Holding
131
New
8
Increased
59
Reduced
46
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$12.5M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$5.24M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$4.48M |
| 4 |
Coca-Cola
KO
|
+$4.08M |
| 5 |
Vanguard Total Bond Market
BND
|
+$2.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$83.5M |
| 2 |
Amgen
AMGN
|
+$4.73M |
| 3 |
Apple
AAPL
|
+$1.51M |
| 4 |
Pfizer
PFE
|
+$812K |
| 5 |
Bristol-Myers Squibb
BMY
|
+$716K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.34% |
| 2 | Healthcare | 6.46% |
| 3 | Consumer Staples | 5.67% |
| 4 | Consumer Discretionary | 5.16% |
| 5 | Technology | 4.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Philip Morris
PM
$301B
| $817K | 0.08% |
+8,702
| New | +$871K |
|
|
77
Pfizer
PFE
$140B
| $787K | 0.08% |
15,200
-15,643
| -51% | -$812K |
|
78
iShares ESG Aware US Aggregate Bond ETF
EAGG
$4.96B
| $759K | 0.08% |
14,702
+2,086
| +17% | +$111K |
|
79
lululemon athletica
LULU
$13B
| $730K | 0.07% |
+2,000
| New | +$651K |
|
80
UnitedHealth
UNH
$382B
| $699K | 0.07% |
1,371
-221
| -14% | -$107K |
|
81
Comcast
CMCSA
$79.1B
| $678K | 0.07% |
14,476
+693
| +5% | +$33.4K |
|
82
RTX Corp
RTX
$287B
| $678K | 0.07% |
6,841
+4,146
| +154% | +$393K |
|
83
Vanguard Small-Cap ETF
VB
$79.5B
| $641K | 0.07% |
+3,018
| New | +$635K |
|
84
Vanguard Growth ETF
VUG
$216B
| $640K | 0.06% |
13,344
| – | – |
|
85
Eli Lilly
LLY
$1.07T
| $604K | 0.06% |
+2,107
| New | +$542K |
|
86
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $561K | 0.06% |
1,243
+253
| +26% | +$113K |
|
87
Qualcomm
QCOM
$176B
| $546K | 0.06% |
3,571
-58
| -2% | -$9.73K |
|
88
Bank of America
BAC
$435B
| $539K | 0.05% |
13,064
-3,167
| -20% | -$143K |
|
89
Honeywell
HON
$77.1B
| $508K | 0.05% |
2,770
+140
| +5% | +$25.9K |
|
90
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
| $507K | 0.05% |
9,705
| – | – |
|
91
Meta Platforms (Facebook)
META
$1.51T
| $475K | 0.05% |
2,134
-367
| -15% | -$91.7K |
|
92
SPDR Gold Trust
GLD
$131B
| $470K | 0.05% |
2,601
+250
| +11% | +$43.9K |
|
93
Intel
INTC
$466B
| $468K | 0.05% |
9,453
-9,733
| -51% | -$482K |
|
94
General Dynamics
GD
$105B
| $444K | 0.05% |
1,840
-608
| -25% | -$135K |
|
95
Target
TGT
$62.1B
| $419K | 0.04% |
1,976
-235
| -11% | -$50.8K |
|
96
Caterpillar
CAT
$409B
| $407K | 0.04% |
1,828
-39
| -2% | -$8.18K |
|
97
Lowe's Companies
LOW
$116B
| $404K | 0.04% |
1,997
-140
| -7% | -$32.2K |
|
98
Zoetis
ZTS
$31.6B
| $400K | 0.04% |
2,119
-385
| -15% | -$76.1K |
|
99
ExxonMobil
XOM
$651B
| $391K | 0.04% |
4,731
-1,183
| -20% | -$92K |
|
100
Danaher
DHR
$135B
| $388K | 0.04% |
1,492
-35
| -2% | -$8.76K |
|
Similar funds
FM
BO
CL
PS
AIL
CGM
H6H
AEPI
Brightworth's Q1 2022 Portfolio in Review
As of Q1 2022, Brightworth held 131 positions worth $987M, down 9.7% from $1.09B the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Brightworth withdrew a net $51.5M in Q1 2022, closing 11 positions and reducing 46 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $716K position sold in full.
By sector, the portfolio is most concentrated in Financials at 7.3% of assets, up from 7% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Brightworth opened a new position in Thermo Fisher Scientific worth $5.39M.
- Brightworth's largest Q1 2022 buy was Thermo Fisher Scientific: 9,121 shares worth $5.39M.
- Brightworth added most to Vanguard Total International Stock ETF in Q1 2022, an estimated $12.5M increase.
- Brightworth's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $83.5M.
- Brightworth fully exited Bristol-Myers Squibb in Q1 2022, selling an estimated $716K.
- Brightworth's ten largest holdings make up 59% of its $987M portfolio in Q1 2022.
- Brightworth opened 8 new positions and closed 11 in Q1 2022.
- Brightworth's portfolio value fell 9.7% quarter-over-quarter to $987M.
Based on Brightworth's 13F filing for Q1 2022, filed 29 Apr 2022.